Ven Bio Global Strategic Fund, L.P. is > 10% Shareholder of Metacrine, Inc.. Currently has a direct ownership of 2.44 Million shares of MTCR, which is worth approximately $0. The most recent transaction as insider was on Oct 25, 2021, when has been sold 540,667 shares (Common Stock) at a price of $1.49 per share, resulting in proceeds of $805,594. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.44M
0% 3M change
0% 12M change
Total Value Held $0

venBio Global Strategic Fund, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 25 2021
SELL
Open market or private sale
$805,594 $1.49 p/Share
540,667 Reduced 18.12%
2,443,421 Common Stock
Oct 22 2021
SELL
Open market or private sale
$123,057 $1.64 p/Share
75,035 Reduced 2.45%
2,984,088 Common Stock
vGS

Ven Bio Global Strategic Fund, L.P.

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on MTCR

Follow Metacrine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTCR shares.

Notify only if

Insider Trading

Get notified when an Metacrine, Inc. insider buys or sells MTCR shares.

Notify only if

News

Receive news related to Metacrine, Inc.

Track Activities on MTCR